[CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)].
作者信息
Meco G, Casacchia M, Zamponi A, Agnoli A
出版信息
Schweiz Rundsch Med Prax. 1976 May 4;65(18):557-9.
PMID:989900
Abstract
摘要
相似文献
1
[CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)].
Schweiz Rundsch Med Prax. 1976 May 4;65(18):557-9.
2
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Acta Neurol (Napoli). 1976 Jul-Aug;31(4):479-48.
3
[Our experience in the treatment of Parkinson's disease with L-dopa plus RO 4-4602 combination].
Acta Neurol (Napoli). 1974 May-Jun;29(3):252-63.
4
[Results of prolonged treatment of Parkinson's disease with the L-dopa-benserazide combination].
Riv Neurol. 1974 Sep-Oct;44(5):303-30.
5
Levodopa treatment of Parkinson's syndrome: past and future.
Adv Neurol. 1990;53:469-73.
6
[Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
No To Shinkei. 1980 Oct;32(10):991-1000.
7
[Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) (author's transl)].
MMW Munch Med Wochenschr. 1974 Jul 12;116(28):1353-6.
8
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].
Arch Invest Med (Mex). 1974;5(2):105-16.
9
Dopamine agonists as primary treatment in Parkinson's disease.
Adv Neurol. 1987;45:519-23.
10
[Lisuride in the combination treatment of Parkinson disease].
Wien Med Wochenschr. 1987 Apr 30;137(7-8):155-9.
引用本文的文献
1
Long-term treatment of Parkinson's disease with bromocriptine.
J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):143-50. doi: 10.1136/jnnp.42.2.143.
Zotero 插件